이엠알

비상장계속사업자

EMR Co.,Ltd.

김일두

Investment Review Report

Auto-filled from disclosures & public data + AI-drafted analysis. Edit, then export to PDF/DOCX.

Editor

1.Deal Terms

2.Valuation / Exit Assumptions

Exit Scenarios100M KRW

3.Fund Eligibility

Fund mandate eligibility — no data, enter manually

Enter fund mandate requirements and applicability (Y/N) to include a table in the report.

4.Capital Changes

Not in DART — enter capital-raise history manually

Enter capital changes such as founding capital and paid-in increases.

5.Stock Options

Enter manually

Enter stock option grant history.

6.Investment Highlights

AI draft — editable

Click 'Generate AI draft' to populate data-grounded investment highlights.

7.Investment Risks

AI draft — editable

Risks are populated after 'Generate AI draft'.

8.Market Analysis

AI draft — editable

9.Business Analysis

AI draft — editable

10.Conclusion (Investment Opinion)

AI draft — editable

11.P&L Projection

Analyst estimates, manual entry (100M KRW). Generates a trend chart & table.

Enter projected revenue / op. profit / net income (100M KRW) by year to add a trend chart and table.
Preview— the document below is saved as PDF/DOCX

Investment Review Report

이엠알

Business Reg. No. 1248146470 · CEO 김일두

I.Investment Overview

Target이엠알 (1248146470)
Investment
Post-deal stake
ValuationPre — / Post —

II.Investment Highlights

No investment highlights written yet.

III.Investment Risks

No risks written yet.

IV.Company Profile

회사명이엠알
영문명EMR Co.,Ltd.
대표자김일두
사업자등록번호1248146470
법인등록번호1348110027442
설립일1996.11.01
종업원수3명

V.Workforce

3

Current headcount · 2026.06 as of

VI.Financial Summary

Per DART disclosure · in 억/만원 (KRW)

Financial trend (100M KRW)

매출액100M KRW155.320211422022104.9202392.2202476.62025
영업이익100M KRW4.920217.920227.120239.320247.22025
순이익100M KRW3.320213.120221.820233.420240.22025
Item20252024202320222021
자산총계180.1억원166.4억원161.8억원132.1억원129.4억원
부채총계145.1억원131.6억원130.3억원101.9억원99.3억원
자본총계35억원34.8억원31.4억원30.2억원30.1억원
매출액76.6억원92.2억원104.9억원142억원155.3억원
영업이익7.2억원9.3억원7.1억원7.9억원4.9억원
순이익1,956만원3.4억원1.8억원3.1억원3.3억원

VII.Financial Ratios

FY2025 basis

9.35%

영업이익률

0.26%

순이익률

0.11%

ROA

0.56%

ROE

414.6%

부채비율

19.43%

자기자본비율

VIII.Valuation & Exit Plan

Exit valuation
Holding period5y
Enter exit assumptions (investment, stake, exit valuation, period) to see MOIC·IRR.

This report compiles disclosure & public data and AI-drafts some sections as a research aid. It is not investment advice; the user bears final responsibility for facts and investment decisions.

이엠알 투심보고서 | Alpha Lenz